Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents

Benzer Materyaller

• INCB050465 (Parsaclisib), a Novel Next-Generation Inhibitor of Phosphoinositide 3-Kinase Delta (PI3Kδ)
  Yazar:: Yue, Eddy W., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment
  Yazar:: Spranger, Stefani, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology
  Yazar:: Yue, Eddy W., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Immunotherapeutic modulation of the suppressive liver and tumor microenvironments
  Yazar:: Chan, Tim, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
  Yazar:: Liu, Phillip C. C., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)